Bio-Plex 200 (Allergens)
Forecast overview
- Subagency
- FDA
- NAICS
- 541990
- Program office
- HFP ACQUISITION
This funding supports the procurement of a Bio-Plex multiplex system that serves as the essential instrumentation platform for the xMAP Food Allergen Detection Assay (xMAP FADA), an advanced multiplex immunoassay developed by FDA to simultaneously detect multiple food allergens, including gluten, in a single analytical test. This procurement is critical for replacing existing instrumentation that has approached the end of its operational reliability, ensuring continued support for ongoing method development and validation studies.
Related federal terms
- NAICS — North American Industry Classification System
Acquisition timeline
- Last verified on RFPCapture
- 2026-08-31
- Estimated solicitation
- 5/2026 (agency estimate)
- Estimated award
- 9/2026 (agency estimate)
- Expected period of performance end
- 9/2026 (agency estimate)
Market context
- NAICS market
- NAICS 541990
- Active contractors in this market
- 5 with relevant federal experience
Contractors with relevant federal experience
Action links
Track this forecast in CaptureIQ
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31